Trial document



drksid header

  DRKS00017687

Trial Description

start of 1:1-Block title

Title

Music-assisted treadmill training in the therapy of Parkinson's disease

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

MATT study

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

[---]*

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Parkinson’s Disease (PD) is one of the main neurodegenerative disease in Germany and in western industry nations with increasing number of patients due to the demographic change. In the course of the disease PD patients suffer from motor and non-motor symptoms. Only a limited number of pharmacotherapies for the symptomatic treatment of PD patients are available and so is the invasive deep brain stimulation (DBS), which is limited to a selected group of patients. Inducing an urgent need for alternative, non-pharmacologic therapy options.
Motor and cognitive therapies are established treatments, however in the usual care routines they are applied independent (if at all) from on another even though a growing understanding of motor function and cognition as linked entities exists. Furthermore patient’s motivation for long-term adherence can be a challenge in progressive disease.
Treadmill training and cueing are successfully applied in routine care of PD patients to improve gait. Patients consider the training with musically auditive cues as especially motivating. A music assisted gait training showed better effects than a usual treadmill training. However, these studies mainly focused on motor functional outcomes, so that a remaining research interest exists to examine the possible effects on cognition. Furthermore, studies rarely include patient-centered outcomes, so that the current project aims at evaluation these. Additionally there is little evidence about the mid-term effects of a music-assisted treadmill training so that these will be evaluated as well.
In the current pilot-project with a randomized controlled design and follow-up telephone interview after six weeks, we aim at the evaluation of feasibility as well as short- and mid-term effects of a music-assisted treadmill training on cognition. Furthermore the patient-centered outcomes of mood, motivation, fatigue, and fun will be compared to an usual ergometer training.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Forwarding of patient-related data:

No

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

[---]*

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00017687
  •   2019/09/25
  •   [---]*
  •   yes
  •   Approved
  •   19-1291, Ethik-Kommission der Medizinischen Fakultät der Universität zu Köln
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  •   U1111-1240-9458 
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   G20 -  Parkinson disease
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   20 min music assisted treadmill training plus regular motor and cognitive rehabilitation therapy for 8 training days
  •   20 min ergometertraining plus regular motor and cognitive rehabilitation therapy for 8 training days
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Randomized controlled trial
  •   Open (masking not used)
  •   [---]*
  •   Active control (effective treament of control group)
  •   Treatment
  •   Parallel
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Cognition
- Overall cognition (MoCA)
- Alertness (TAP)
- selective Attention (TAP)
- reaction time (WTS, RT-S5)
- Inhibition (TAP)
- cognitive flexibility (TAP; TMT B/A)
- word fluency (RWT)
- short-term memory (number and Digit span of WMS-R; visual reproduction of WMS-R)
- working memory (number and Digit span of WMS-R)
- mentale rotation (LPS-2, Subtest 7)
- visual scanning (TAP, TMT- A)
- learning strateges (CVLT; TOL-D)

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Motor Function
- gros motor function: Fist Closure Frequency
- fine motor function: NHPT
- Balance/ risk for falls: BBS; TUG; TUG+DT
- gait: 10mGT
- Freezing: FoGQ
- functional independence: FIM

Ability to sychronize

Motivation, mood, fatigue und fun while training

Disease severity (H&Y; UPDRS)

Depression (GDS)

Quality of life (PDQ-39; EQ-5D)

Activity level (IPAQ)

Fatigue (PFS- 16)

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2019/09/26
  •   40
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   110   Years
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

- Patients with Parkinson's disease
- no further neurological or psychiatric disease, that interferes with study participation
- no hint at a medium severe depression(cut-off: < 10 Points on Geriatric Depression Scale)
- no other disease (cardiologic or orthpedic), that interferes with study participation
- undisturbed or sufficiently corrected vision and hearing
- Participant speaks German
- Patient can provide informed consent (cut-off: Montreal Cognitive Assessment (MoCA) > 17 points; Freitas et al., 2014)
- Patient can follow therapeutic instructions
- Patient provides written consent for study participation
- scheduled stay of at least 14 days at neurological rehabilitations center Godeshöhe e.V.

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

- severe disturbtion of vigilance, of speech or psychiatric, which interfere with understanding of study aims and/ or instructions, and decrease safety during
- daily uncontrolled changes in medication or Stimulation Settings, which would decrease safety

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Medizinische Psychologie | Neuropsychologie und Gender Studies Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)
    • Ms.  Prof. Dr. rer. nat.  Elke  Kalbe 
    • Kerpenerstr. 62
    • 50937  Köln
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address other
    • Neurologisches Rehabilitationszentrum Godeshöhe e. V.
    • Mr.  Diplom Psychologe  Jochen  Saliger 
    • Waldstr. 2-10
    • 53177  Bonn
    • Germany
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address scientific-contact
    • Medizinische Psychologie | Neuropsychologie und Gender Studies Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)
    • Ms.  Prof. Dr. rer. nat.  Elke  Kalbe 
    • Kerpenerstr. 62
    • 50937  Köln
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Medizinische Psychologie | Neuropsychologie und Gender Studies Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)
    • Ms.  MSc  Mareike  Gooßes 
    • Kerpenerstr. 62
    • 50937  Köln
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Medizinische Psychologie | Neuropsychologie und Gender Studies und Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)
    • Ms.  Prof. Dr. med  Elke  Kalbe 
    • Kerpener Str. 62
    • 50937  Köln
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting ongoing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.